Rivaroxaban (Xarelto) appeared on par with warfarin for prevention in atrial fibrillation (Afib) with a bioprosthetic mitral valve, the RIVER trial showed. Mean time to death, major cardiovascular ...
Helping to fill an evidence gap, a retrospective review of a large database of US commercial health claims indicates that in patients with valvular atrial fibrillation (AF), direct oral anticoagulants ...
A large, population-based study of patients with atrial fibrillation (AF) and valvular heart disease (VHD) found that use of apixaban was associated with a lower rate of ischemic stroke or systemic ...
No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...
Direct oral anticoagulants were associated with lower risks of ischemic stroke or systemic embolism and bleeding compared with warfarin. The study included patients with atrial fibrillation (AF) and ...
For patients with non-valvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use of a device to close off the left atrial appendage in the heart—a small ...
For patients with non-valvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use of a device to close off the left atrial appendage in the heart—a small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results